カテゴリー： Market Monitor Global, 世界, 医療/バイオ

生殖器・泌尿器治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Genito-Urinary Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5586）◆商品コード：MMG23JU5586
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Genito-Urinary Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの生殖器・泌尿器治療薬市場規模と予測を収録しています。・世界の生殖器・泌尿器治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の生殖器・泌尿器治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生殖器・泌尿器治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

生殖器・泌尿器治療薬のグローバル主要企業は、Daiichi Sankyo Company、 Pfizer、 Bayer、 Astellas Pharma、 Allergan、 GSK、 Otsuka Pharmaceutical、 Sanofiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、生殖器・泌尿器治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の生殖器・泌尿器治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の生殖器・泌尿器治療薬市場：タイプ別市場シェア、2022年
・OTC、Rx医薬品

世界の生殖器・泌尿器治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の生殖器・泌尿器治療薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の生殖器・泌尿器治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の生殖器・泌尿器治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における生殖器・泌尿器治療薬のグローバル売上、2018年-2023年
・主要企業における生殖器・泌尿器治療薬のグローバル売上シェア、2022年
・主要企業における生殖器・泌尿器治療薬のグローバル販売量、2018年-2023年
・主要企業における生殖器・泌尿器治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Daiichi Sankyo Company、 Pfizer、 Bayer、 Astellas Pharma、 Allergan、 GSK、 Otsuka Pharmaceutical、 Sanofi

*************************************************************

・調査・分析レポートの概要
生殖器・泌尿器治療薬市場の定義
市場セグメント
世界の生殖器・泌尿器治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生殖器・泌尿器治療薬市場規模
世界の生殖器・泌尿器治療薬市場規模：2022年 VS 2029年
世界の生殖器・泌尿器治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生殖器・泌尿器治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生殖器・泌尿器治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：OTC、Rx医薬品
生殖器・泌尿器治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
生殖器・泌尿器治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別生殖器・泌尿器治療薬市場規模 2022年と2029年
地域別生殖器・泌尿器治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Daiichi Sankyo Company、 Pfizer、 Bayer、 Astellas Pharma、 Allergan、 GSK、 Otsuka Pharmaceutical、 Sanofi
...

Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
This report aims to provide a comprehensive presentation of the global market for Genito-Urinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genito-Urinary Drugs. This report contains market size and forecasts of Genito-Urinary Drugs in global, including the following market information:
Global Genito-Urinary Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Genito-Urinary Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Genito-Urinary Drugs companies in 2022 (%)
The global Genito-Urinary Drugs market was valued at US$ 29340 million in 2022 and is projected to reach US$ 36470 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Genito-Urinary Drugs include Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, Allergan, GSK, Otsuka Pharmaceutical and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genito-Urinary Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genito-Urinary Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Genito-Urinary Drugs Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global Genito-Urinary Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Genito-Urinary Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Other
Global Genito-Urinary Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Genito-Urinary Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genito-Urinary Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Genito-Urinary Drugs revenues share in global market, 2022 (%)
Key companies Genito-Urinary Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Genito-Urinary Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
Allergan
GSK
Otsuka Pharmaceutical
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genito-Urinary Drugs, market overview.
Chapter 2: Global Genito-Urinary Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genito-Urinary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Genito-Urinary Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Genito-Urinary Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genito-Urinary Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genito-Urinary Drugs Overall Market Size
2.1 Global Genito-Urinary Drugs Market Size: 2022 VS 2029
2.2 Global Genito-Urinary Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Genito-Urinary Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Genito-Urinary Drugs Players in Global Market
3.2 Top Global Genito-Urinary Drugs Companies Ranked by Revenue
3.3 Global Genito-Urinary Drugs Revenue by Companies
3.4 Global Genito-Urinary Drugs Sales by Companies
3.5 Global Genito-Urinary Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Genito-Urinary Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Genito-Urinary Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Genito-Urinary Drugs Players in Global Market
3.8.1 List of Global Tier 1 Genito-Urinary Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Genito-Urinary Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Genito-Urinary Drugs Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type – Global Genito-Urinary Drugs Revenue & Forecasts
4.2.1 By Type – Global Genito-Urinary Drugs Revenue, 2018-2023
4.2.2 By Type – Global Genito-Urinary Drugs Revenue, 2024-2029
4.2.3 By Type – Global Genito-Urinary Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Genito-Urinary Drugs Sales & Forecasts
4.3.1 By Type – Global Genito-Urinary Drugs Sales, 2018-2023
4.3.2 By Type – Global Genito-Urinary Drugs Sales, 2024-2029
4.3.3 By Type – Global Genito-Urinary Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Genito-Urinary Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Genito-Urinary Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application – Global Genito-Urinary Drugs Revenue & Forecasts
5.2.1 By Application – Global Genito-Urinary Drugs Revenue, 2018-2023
5.2.2 By Application – Global Genito-Urinary Drugs Revenue, 2024-2029
5.2.3 By Application – Global Genito-Urinary Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Genito-Urinary Drugs Sales & Forecasts
5.3.1 By Application – Global Genito-Urinary Drugs Sales, 2018-2023
5.3.2 By Application – Global Genito-Urinary Drugs Sales, 2024-2029
5.3.3 By Application – Global Genito-Urinary Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Genito-Urinary Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Genito-Urinary Drugs Market Size, 2022 & 2029
6.2 By Region – Global Genito-Urinary Drugs Revenue & Forecasts
6.2.1 By Region – Global Genito-Urinary Drugs Revenue, 2018-2023
6.2.2 By Region – Global Genito-Urinary Drugs Revenue, 2024-2029
6.2.3 By Region – Global Genito-Urinary Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Genito-Urinary Drugs Sales & Forecasts
6.3.1 By Region – Global Genito-Urinary Drugs Sales, 2018-2023
6.3.2 By Region – Global Genito-Urinary Drugs Sales, 2024-2029
6.3.3 By Region – Global Genito-Urinary Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Genito-Urinary Drugs Revenue, 2018-2029
6.4.2 By Country – North America Genito-Urinary Drugs Sales, 2018-2029
6.4.3 US Genito-Urinary Drugs Market Size, 2018-2029
6.4.4 Canada Genito-Urinary Drugs Market Size, 2018-2029
6.4.5 Mexico Genito-Urinary Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Genito-Urinary Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Genito-Urinary Drugs Sales, 2018-2029
6.5.3 Germany Genito-Urinary Drugs Market Size, 2018-2029
6.5.4 France Genito-Urinary Drugs Market Size, 2018-2029
6.5.5 U.K. Genito-Urinary Drugs Market Size, 2018-2029
6.5.6 Italy Genito-Urinary Drugs Market Size, 2018-2029
6.5.7 Russia Genito-Urinary Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Genito-Urinary Drugs Market Size, 2018-2029
6.5.9 Benelux Genito-Urinary Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Genito-Urinary Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Genito-Urinary Drugs Sales, 2018-2029
6.6.3 China Genito-Urinary Drugs Market Size, 2018-2029
6.6.4 Japan Genito-Urinary Drugs Market Size, 2018-2029
6.6.5 South Korea Genito-Urinary Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Genito-Urinary Drugs Market Size, 2018-2029
6.6.7 India Genito-Urinary Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Genito-Urinary Drugs Revenue, 2018-2029
6.7.2 By Country – South America Genito-Urinary Drugs Sales, 2018-2029
6.7.3 Brazil Genito-Urinary Drugs Market Size, 2018-2029
6.7.4 Argentina Genito-Urinary Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Genito-Urinary Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Genito-Urinary Drugs Sales, 2018-2029
6.8.3 Turkey Genito-Urinary Drugs Market Size, 2018-2029
6.8.4 Israel Genito-Urinary Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Genito-Urinary Drugs Market Size, 2018-2029
6.8.6 UAE Genito-Urinary Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Daiichi Sankyo Company
7.1.1 Daiichi Sankyo Company Company Summary
7.1.2 Daiichi Sankyo Company Business Overview
7.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Major Product Offerings
7.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Daiichi Sankyo Company Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Genito-Urinary Drugs Major Product Offerings
7.2.4 Pfizer Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Genito-Urinary Drugs Major Product Offerings
7.3.4 Bayer Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Astellas Pharma
7.4.1 Astellas Pharma Company Summary
7.4.2 Astellas Pharma Business Overview
7.4.3 Astellas Pharma Genito-Urinary Drugs Major Product Offerings
7.4.4 Astellas Pharma Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharma Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Genito-Urinary Drugs Major Product Offerings
7.5.4 Allergan Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 GSK
7.6.1 GSK Company Summary
7.6.2 GSK Business Overview
7.6.3 GSK Genito-Urinary Drugs Major Product Offerings
7.6.4 GSK Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.6.5 GSK Key News & Latest Developments
7.7 Otsuka Pharmaceutical
7.7.1 Otsuka Pharmaceutical Company Summary
7.7.2 Otsuka Pharmaceutical Business Overview
7.7.3 Otsuka Pharmaceutical Genito-Urinary Drugs Major Product Offerings
7.7.4 Otsuka Pharmaceutical Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Otsuka Pharmaceutical Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Genito-Urinary Drugs Major Product Offerings
7.8.4 Sanofi Genito-Urinary Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
8 Global Genito-Urinary Drugs Production Capacity, Analysis
8.1 Global Genito-Urinary Drugs Production Capacity, 2018-2029
8.2 Genito-Urinary Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Genito-Urinary Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Genito-Urinary Drugs Supply Chain Analysis
10.1 Genito-Urinary Drugs Industry Value Chain
10.2 Genito-Urinary Drugs Upstream Market
10.3 Genito-Urinary Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Genito-Urinary Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Genito-Urinary Drugs in Global Market
Table 2. Top Genito-Urinary Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Genito-Urinary Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Genito-Urinary Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Genito-Urinary Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Genito-Urinary Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Genito-Urinary Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Genito-Urinary Drugs Product Type
Table 9. List of Global Tier 1 Genito-Urinary Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genito-Urinary Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Genito-Urinary Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Genito-Urinary Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Genito-Urinary Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Genito-Urinary Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Genito-Urinary Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Genito-Urinary Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Genito-Urinary Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Genito-Urinary Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Genito-Urinary Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Genito-Urinary Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Genito-Urinary Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Genito-Urinary Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Genito-Urinary Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Genito-Urinary Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Genito-Urinary Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Genito-Urinary Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Genito-Urinary Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Genito-Urinary Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Genito-Urinary Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Genito-Urinary Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Genito-Urinary Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Genito-Urinary Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Genito-Urinary Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Genito-Urinary Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Genito-Urinary Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Genito-Urinary Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Genito-Urinary Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Genito-Urinary Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Genito-Urinary Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Genito-Urinary Drugs Sales, (K Units), 2024-2029
Table 46. Daiichi Sankyo Company Company Summary
Table 47. Daiichi Sankyo Company Genito-Urinary Drugs Product Offerings
Table 48. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Daiichi Sankyo Company Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Genito-Urinary Drugs Product Offerings
Table 52. Pfizer Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Genito-Urinary Drugs Product Offerings
Table 56. Bayer Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Astellas Pharma Company Summary
Table 59. Astellas Pharma Genito-Urinary Drugs Product Offerings
Table 60. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Astellas Pharma Key News & Latest Developments
Table 62. Allergan Company Summary
Table 63. Allergan Genito-Urinary Drugs Product Offerings
Table 64. Allergan Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Allergan Key News & Latest Developments
Table 66. GSK Company Summary
Table 67. GSK Genito-Urinary Drugs Product Offerings
Table 68. GSK Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. GSK Key News & Latest Developments
Table 70. Otsuka Pharmaceutical Company Summary
Table 71. Otsuka Pharmaceutical Genito-Urinary Drugs Product Offerings
Table 72. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Otsuka Pharmaceutical Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Genito-Urinary Drugs Product Offerings
Table 76. Sanofi Genito-Urinary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. Genito-Urinary Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Genito-Urinary Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Genito-Urinary Drugs Production by Region, 2018-2023 (K Units)
Table 81. Global Genito-Urinary Drugs Production by Region, 2024-2029 (K Units)
Table 82. Genito-Urinary Drugs Market Opportunities & Trends in Global Market
Table 83. Genito-Urinary Drugs Market Drivers in Global Market
Table 84. Genito-Urinary Drugs Market Restraints in Global Market
Table 85. Genito-Urinary Drugs Raw Materials
Table 86. Genito-Urinary Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Genito-Urinary Drugs Downstream
Table 88. Genito-Urinary Drugs Downstream Clients in Global Market
Table 89. Genito-Urinary Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Genito-Urinary Drugs Segment by Type in 2022
Figure 2. Genito-Urinary Drugs Segment by Application in 2022
Figure 3. Global Genito-Urinary Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genito-Urinary Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genito-Urinary Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Genito-Urinary Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Genito-Urinary Drugs Revenue in 2022
Figure 9. By Type - Global Genito-Urinary Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Genito-Urinary Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Genito-Urinary Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Genito-Urinary Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Genito-Urinary Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Genito-Urinary Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 23. US Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 28. Germany Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 37. China Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Genito-Urinary Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Genito-Urinary Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Genito-Urinary Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Genito-Urinary Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Genito-Urinary Drugs by Region, 2022 VS 2029
Figure 54. Genito-Urinary Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 生殖器・泌尿器治療薬の世界市場見通し2023年-2029年(Genito-Urinary Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 泌尿器・生殖器治療薬の世界市場2022：OTC、Rxドラッグ
  • 尿路感染症（UTI）治療の世界市場2022年～2029年：薬剤別、疾患別、地域別
  • 抗菌コーティング加工尿管の世界市場見通し2023年-2029年
  • 尿失禁修復用外科スリングの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆